Did you know that Hanson Wade offer more than just conferences? We have a whole suite of products to help you to continue navigating the unique development, manufacturing, and commercial challenges to drive forward the next wave of safe, effective gene therapies.
Curated through close collaboration with industry leaders to give you high-quality and granular insight across all disease indications. By delving into early R&D, clinical safety and efficacy, manufacturing, regulatory, and market access challenges, as well as showcasing the next generation of novel vector development in AAV and beyond, we can together realize the full promise of gene therapies together.
Take a look at our Gene Therapy products:
The only global gene therapy network focused on rare disorders. Connecting gene therapy specialists to tackle key shared clinical, manufacturing and regulatory challenges to accelerate the delivery of safe, efficacious and accessible gene therapies to rare disease patients faster
A trusted provider of market intelligence for anyone looking to understand the complexities of Gene Therapy research and development. We offer a range of qualitative and quantitative research services including KOL interviews, market landscape analysis, competitive profiling, brand surveys and value proposition testing.
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive data, provide our customers with unparalleled visibility of the drug and trial landscape.
Focused on the most challenging problems facing every aspect of the industry, sourcing leading experts with innovative solutions and distilling this into market-leading global conferences. We are committed to building every event in the series with the goal of truly helping you gain better insight and ultimately helping drive forward the gene therapy community together.